These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30593830)

  • 1. Targeting cell-bound MUC1 on myelomonocytic, monocytic leukemias and phenotypically defined leukemic stem cells with anti-SEA module antibodies.
    Guillaume T; Dehame V; Chevallier P; Peterlin P; Garnier A; Grégoire M; Pichinuk E; Rubinstein DB; Wreschner DH
    Exp Hematol; 2019 Feb; 70():97-108. PubMed ID: 30593830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo anti-MUC1
    Pichinuk E; Chalik M; Benhar I; Ginat-Koton R; Ziv R; Smorodinsky NI; Haran G; Garbar C; Bensussan A; Meeker A; Guillaume T; Rubinstein DB; Wreschner DH
    Cancer Immunol Immunother; 2020 Jul; 69(7):1337-1352. PubMed ID: 32219500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells.
    Stroopinsky D; Rosenblatt J; Ito K; Mills H; Yin L; Rajabi H; Vasir B; Kufe T; Luptakova K; Arnason J; Nardella C; Levine JD; Joyce RM; Galinsky I; Reiter Y; Stone RM; Pandolfi PP; Kufe D; Avigan D
    Cancer Res; 2013 Sep; 73(17):5569-79. PubMed ID: 23867470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MUC1 oncoprotein as a functional target: immunotoxin binding to alpha/beta junction mediates cell killing.
    Rubinstein DB; Karmely M; Pichinuk E; Ziv R; Benhar I; Feng N; Smorodinsky NI; Wreschner DH
    Int J Cancer; 2009 Jan; 124(1):46-54. PubMed ID: 18821582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody targeting of cell-bound MUC1 SEA domain kills tumor cells.
    Pichinuk E; Benhar I; Jacobi O; Chalik M; Weiss L; Ziv R; Sympson C; Karwa A; Smorodinsky NI; Rubinstein DB; Wreschner DH
    Cancer Res; 2012 Jul; 72(13):3324-36. PubMed ID: 22507854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity.
    Pagliaro LC; Liu B; Munker R; Andreeff M; Freireich EJ; Scheinberg DA; Rosenblum MG
    Clin Cancer Res; 1998 Aug; 4(8):1971-6. PubMed ID: 9717827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of CD302 as a potential therapeutic target for acute myeloid leukemia.
    Lo TH; Abadir E; Gasiorowski RE; Kabani K; Ramesh M; Orellana D; Fromm PD; Kupresanin F; Newman E; Cunningham I; Hart DNJ; Silveira PA; Clark GJ
    PLoS One; 2019; 14(5):e0216368. PubMed ID: 31075107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional alterations of Lin-CD34+CD38+ cells in chronic myelomonocytic leukemia and on progression to acute leukemia.
    Sun Q; So CC; Yip SF; Wan TS; Ma SK; Chan LC
    Leuk Res; 2008 Sep; 32(9):1374-81. PubMed ID: 18372040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer.
    Hartman M; Baruch A; Ron I; Aderet Y; Yoeli M; Sagi-Assif O; Greenstein S; Stadler Y; Weiss M; Harness E; Yaakubovits M; Keydar I; Smorodinsky NI; Wreschner DH
    Int J Cancer; 1999 Jul; 82(2):256-67. PubMed ID: 10389761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of murine and humanized anti-CD33, gelonin immunotoxins reactive against myeloid leukemias.
    McGraw KJ; Rosenblum MG; Cheung L; Scheinberg DA
    Cancer Immunol Immunother; 1994 Dec; 39(6):367-74. PubMed ID: 8001024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1/X protein immunization enhances cDNA immunization in generating anti-MUC1 alpha/beta junction antibodies that target malignant cells.
    Rubinstein DB; Karmely M; Ziv R; Benhar I; Leitner O; Baron S; Katz BZ; Wreschner DH
    Cancer Res; 2006 Dec; 66(23):11247-53. PubMed ID: 17145869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface-associated anti-MUC1-derived signal peptide antibodies: implications for cancer diagnostics and therapy.
    Kovjazin R; Horn G; Smorodinsky NI; Shapira MY; Carmon L
    PLoS One; 2014; 9(1):e85400. PubMed ID: 24416403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A; Gillis D; Lewis I
    J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD16
    Williams BA; Wang XH; Leyton JV; Maghera S; Deif B; Reilly RM; Minden MD; Keating A
    Haematologica; 2018 Oct; 103(10):1720-1729. PubMed ID: 29976748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation.
    Abadir E; Gasiorowski RE; Lai K; Kupresanin F; Romano A; Silveira PA; Lo TH; Fromm PD; Kennerson ML; Iland HJ; Ho PJ; Hogarth PM; Bradstock K; Hart DNJ; Clark GJ
    Mol Oncol; 2019 Oct; 13(10):2107-2120. PubMed ID: 31338922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs.
    Nguyen DH; Ball ED; Varki A
    Exp Hematol; 2006 Jun; 34(6):728-35. PubMed ID: 16728277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Antibodies Targeting MUC1-C Showed Anti-Metastasis and Growth-Inhibitory Effects on Human Breast Cancer Cells.
    Kim MJ; Choi JR; Tae N; Wi TM; Kim KM; Kim DH; Lee ES
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MUC1 SEA module is a self-cleaving domain.
    Levitin F; Stern O; Weiss M; Gil-Henn C; Ziv R; Prokocimer Z; Smorodinsky NI; Rubinstein DB; Wreschner DH
    J Biol Chem; 2005 Sep; 280(39):33374-86. PubMed ID: 15987679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34(+) cells of juvenile myelomonocytic leukemia.
    Nakazawa Y; Matsuda K; Kurata T; Sueki A; Tanaka M; Sakashita K; Imai C; Wilson MH; Koike K
    J Hematol Oncol; 2016 Mar; 9():27. PubMed ID: 26983639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid Leukemia.
    Anami Y; Deng M; Gui X; Yamaguchi A; Yamazaki CM; Zhang N; Zhang CC; An Z; Tsuchikama K
    Mol Cancer Ther; 2020 Nov; 19(11):2330-2339. PubMed ID: 32879051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.